Derek R. Johnson

4.1k total citations · 1 hit paper
136 papers, 2.5k citations indexed

About

Derek R. Johnson is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Derek R. Johnson has authored 136 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 40 papers in Radiology, Nuclear Medicine and Imaging and 32 papers in Epidemiology. Recurrent topics in Derek R. Johnson's work include Glioma Diagnosis and Treatment (52 papers), Meningioma and schwannoma management (24 papers) and Radiomics and Machine Learning in Medical Imaging (19 papers). Derek R. Johnson is often cited by papers focused on Glioma Diagnosis and Treatment (52 papers), Meningioma and schwannoma management (24 papers) and Radiomics and Machine Learning in Medical Imaging (19 papers). Derek R. Johnson collaborates with scholars based in United States, Italy and United Kingdom. Derek R. Johnson's co-authors include Brian Patrick O’Neill, Timothy J. Kaufmann, Caterina Giannini, Evanthia Galanis, Julie E. Hammack, Joon H. Uhm, Heather Leeper, Paul D. Brown, Jennifer D. Parker and J. Guérin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Derek R. Johnson

121 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glioblastoma survival in the United States before and during the temozolomide era

2011 597 citations Derek R. Johnson, Brian Patrick O’Neill profile →

Peers

Countries citing papers authored by Derek R. Johnson

Since Specialization

Citations

This map shows the geographic impact of Derek R. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek R. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek R. Johnson more than expected).

Fields of papers citing papers by Derek R. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek R. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek R. Johnson. The network helps show where Derek R. Johnson may publish in the future.

Co-authorship network of co-authors of Derek R. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Derek R. Johnson. A scholar is included among the top collaborators of Derek R. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek R. Johnson. Derek R. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma 2025 ·Neuro-Oncology ·William G. Breen, Jesse G. Dixon, S. Keith Anderson, Jann N. Sarkaria, Paul D. Brown, Elizabeth Yan, Sani H. Kizilbash, Evanthia Galanis, Daniel M. Anderson, David Tran, Miroslaw Mazurczak, Derek R. Johnson, Francois J. Geoffroy, (unknown), Nadia N. Laack	0
2	Staging Alzheimer’s disease through amyloid and tau PET 2025 ·Brain ·Derek R. Johnson, Heather J. Wiste, Val J. Lowe, Christopher G. Schwarz, David S. Knopman, Prashanthi Vemuri, Kejal Kantarci, Bradley F. Boeve, Jonathan Graff‐Radford, Petrice M. Cogswell, Matthew L. Senjem, Terry M. Therneau, Michael Griswold, (unknown), Ronald Petersen, Clifford R. Jack	0
3	Reversal of Anticoagulation in Intracranial Hemorrhage 2025 ·Contemporary Neurosurgery ·(unknown), Derek R. Johnson, (unknown), (unknown), (unknown), (unknown), (unknown), Bart M. Demaerschalk	0
4	Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered? 2024 ·Journal of Neuropathology & Experimental Neurology ·(unknown), (unknown), Derek R. Johnson, (unknown), (unknown), Vera Paulson, (unknown), Zied Abdullaev, Martha Quezado, Patrick J. Cimino, Drew Pratt, (unknown), (unknown), Dirce Maria Carraro, Giovana Tardin Torrezan, (unknown), Leslie Domenici Kulikowski, Felipe D’Almeida Costa, Kenneth Aldape, Cristiane M. Ida	4
5	Neurologic Symptoms After¹⁷⁷Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience 2024 ·Journal of Nuclear Medicine ·Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, (unknown), (unknown), Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor, A. Tuba Kendi	0
6	7T MRI for Cushing Disease: A Single-Institution Experience and Literature Review 2024 ·American Journal of Neuroradiology ·Ian T. Mark, Kirk M. Welker, Dana Erickson, Derek R. Johnson, Girish Bathla, Steven A. Messina, (unknown), Jamie J. Van Gompel	2
7	Back to the Future: Dynamic Contrast-Enhanced Photon-Counting Detector CT for the Detection of Pituitary Adenoma in Cushing Disease 2024 ·American Journal of Neuroradiology ·Ian T. Mark, Jamie J. Van Gompel, Irina Bancos, (unknown), Derek R. Johnson, Girish Bathla, Ajay A. Madhavan, (unknown), Lifeng Yu	5
8	A Prospective, Phase II Study of 177Lu-Dotatate in Patients with Surgery- and Radiation-Refractory Meningioma: Results of the WHO Grade II/III Cohort 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Kenneth W. Merrell, Derek R. Johnson, (unknown), Michael W. Ruff, (unknown), (unknown), Daniel H. Lachance, (unknown), Elizabeth Yan, Ufuk Şener, (unknown), (unknown), P. Brown, Nadia N. Laack, Geoffrey B. Johnson	4
9	State of Art of Molecular Imaging in the Diagnosis and Treatment of Dementia 2024 ·American Journal of Geriatric Psychiatry ·Jacob G. Dubroff, Derek R. Johnson, Hugo Botha	1
10	Fruquintinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Multiply Metastatic Rectal Cancer 2024 ·Clinical Colorectal Cancer ·(unknown), Uğur Sener, Derek R. Johnson, (unknown), (unknown)	1
11	Evaluation of 18F-DOPA PET Imaging Features and Impact on Radiation Target Volumes for Patients with Oligodendroglioma 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Amit Kessel, (unknown), Derek R. Johnson, (unknown), (unknown), Anita Mahajan, Ufuk Şener, Terry C. Burns, Joon H. Uhm, (unknown), Debra H. Brinkmann, (unknown)	1
12	Genomic markers of recurrence risk in atypical meningioma following gross total resection 2023 ·Neuro-Oncology Advances ·Rachael A. Vaubel, Rahul Kumar, Taylor M. Weiskittel, Sarah M. Jenkins, Surendra Dasari, Joon H. Uhm, Daniel H. Lachance, Paul D. Brown, Jamie J. Van Gompel, Robert B. Jenkins, Benjamin R. Kipp, William R. Sukov, Caterina Giannini, Derek R. Johnson, Aditya Raghunathan	15
13	Benign Enhancing Foramen Magnum Lesions 2023 ·American Journal of Neuroradiology ·Ian T. Mark, David F. Black, John C. Benson, Norbert G. Campeau, Derek R. Johnson, Steven A. Messina, Caterina Giannini, Ian F. Parney, Pearse Morris	0
14	Diffuse Calvarial Hyperostosis and Spontaneous Intracranial Hypotension: A Case-Control Study 2022 ·American Journal of Neuroradiology ·(unknown), Derek R. Johnson, John C. Benson, Dong Kun Kim, Patrick H. Luetmer, Darya P. Shlapak, (unknown), Matthew P. Johnson, Jeremy K. Cutsforth‐Gregory, Carrie M. Carr	8
15	Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma 2018 ·Neuro-Oncology Practice ·Michael W. Ruff, Jan C. Buckner, Derek R. Johnson, Martin J. van den Bent, Marjolein Geurts	10
16	Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI 2017 ·American Journal of Neuroradiology ·Derek R. Johnson, Felix E. Diehn, Caterina Giannini, Robert B. Jenkins, Sarah M. Jenkins, Ian F. Parney, Timothy J. Kaufmann	55
17	Case-Based Review: newly diagnosed glioblastoma 2015 ·Neuro-Oncology Practice ·Derek R. Johnson, Shannon Fogh, Caterina Giannini, Timothy J. Kaufmann, Aditya Raghunathan, Philip V. Theodosopoulos, Jennifer Clarke	18
18	Patellofemoral joint replacement, an evolving concept 2014 ·The Knee ·(unknown), J. Brilhault, Norberto Confalonieri, Derek R. Johnson, Emmanuel Thienpont	26
19	Mortality and Discharge to Home After Closed Brain Biopsy: Analysis of 3523 Cases from the State of California, 2003-2009 2012 ·World Neurosurgery ·Derek R. Johnson, Brian Patrick O’Neill, Paul A. Decker, Matt Kosel, Giuseppe Lanzino, Julie E. Hammack	14
20	Rapid Symptomatic and Radiographic Evolution After Presumed Spontaneous Infarction of a Meningioma 2012 ·The Neurologist ·Derek R. Johnson, Timothy J. Kaufmann	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact